Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Dig Dis Sci. 2013 Sep 20;59(1):46–56. doi: 10.1007/s10620-013-2870-z

Table 5.

Multivariable analyses of factors associated with HBV monitoring and HCC surveillance

Chronic HBV Monitoring

Variable Odds Ratio (95% CI) *P-Value

Patient age (per decade) 0.99 (0.98–1.00) 0.026

Patient male gender 1.08 (0.92–1.28) 0.358

Patient race (vs. Caucasian)
  Asian 4.18 (2.40–7.27) <0.001
  Black 1.46 (0.74–2.85) 0.273
  Latino 2.13 (0.75–6.04) 0.156
  Other 3.88 (1.59–7.80) 0.003

Patient insured 0.86 (0.69–1.07) 0.177

Provider age (per decade) 0.87 (0.60–1.27) 0.480

Provider male gender 0.99 (0.98–1.00) 0.518

Asian provider race (vs. non-Asian) 1.00 (0.99–1.01) 0.638

Clinic practice comprised of > 25% Asian patients 1.00 (0.99–1.00) 0.444

Provider knowledge score 1.06 (0.79–1.40) 0.712

Provider attitude score 0.99 (0.78–1.27) 0.965

Provider barrier score 1.06 (0.78–1.43) 0.722

Provider familiarity with AASLD HBV guidelines 1.02 (1.00–1.03) 0.012

HCC Surveillance

Variable Odds Ratio (95% CI) *P-Value

Patient male gender 0.94 (0.74–1.19) 0.616

Patient insured 1.32 (0.74–2.36) 0.353

Provider age (per decade) 0.18 (0.07–0.45) <0.001

Provider male gender 0.99 (0.98–1.04) 0.867

Asian provider race (vs. non-Asian) 1.02 (1.01–1.03) <0.001

Clinic practice comprised of >25% Asian patients 0.97 (0.95–0.99) 0.006

Provider knowledge score 1.99 (1.14–3.48) 0.016

Provider attitude score 1.48 (1.08–2.03) 0.014

Provider barrier score 0.45 (0.24–0.85) 0.013

Provider familiarity with AASLD HBV guidelines 0.99 (0.97–1.00) 0.095